U.S. drops contract with Acambis for smallpox vaccine

The U.S. government canceled a contract with the U.K.'s Acambis for providing smallpox vaccine, saying the vaccine maker's new, weakened vaccine was "no longer highly rated" on technical grounds. Acambis CEO Gordon Cameron said he has asked for an urgent meeting with U.S. health authorities to find out why Acambis was dropped. "We believe that our proposal would have met the requirements of the government, especially given our track record in the biodefence field," Cameron said.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT